Intramedullary Spinal Cord Metastasis from Urothelial Carcinoma
Michael Spinrad1, Pouya Entezami1*, David Jones2 and John Dalfino1
1Department of Neurosurgery, Albany Medical College, Albany, NY, USA
2Department of Pathology, Albany Medical College, Albany, NY, USA
*Corresponding Author: Pouya Entezami, Department of Neurosurgery, Albany Medical College, Albany, NY, USA.
May 01, 2021; Published: May 25, 2021
&nbs; Intramedullary spinal cord metastases (ISCM) are rare neoplasms often associated with significant neurological deterioration. Spinal cord metastases secondary to bladder carcinoma are particularly rare. We report a 56-year-old male found to have an intradural intramedullary lesion at T12. A bladder mass was also discovered on ultrasound, as well as additional systemic metastases. A dorsal approach was undertaken for the spinal cord lesion. Bladder carcinoma and ISCM were confirmed histopathologically. ISCM carries a poor prognosis and information is limited to case reports and series. Early recognition could improve patient therapy and quality of life.
Keywords: Bladder Carcinoma; Intramedullary Spinal Cord Metastasis; Neurooncology; Spinal Cord Surgery
- Crowley RW., et al. “Intramedullary spinal cord metastasis from bladder carcinoma: case report”. Neurosurgery3 (2008): E611-612 discussion E12.
- Abdulazim A., et al. “Intramedullary spinal cord metastasis and multiple brain metastases from urothelial carcinoma”. Journal of Clinical Neuroscience 10 (2011): 1405-1407.
- Dam-Hieu P., et al. “Retrospective study of 19 patients with intramedullary spinal cord metastasis”. Clinical Neurology and Neurosurgery 1 (2009): 10-17.
- Anderson TS., et al. “Neurologic complications of bladder carcinoma: a review of 359 cases”. Cancer9 (2003): 2267-2272.
- Sung WS., et al. “Intramedullary spinal cord metastases: a 20-year institutional experience with a comprehensive literature review”. World Neurosurgery 79 (2013): 576-584.
- Costigan DA and Winkelman MD. “Intramedullary spinal cord metastasis. A clinicopathological study of 13 cases”. Journal of Neurosurgery2 (1985): 227-233.
- Goyal A., et al. “Intramedullary spinal cord metastases: an institutional review of survival and outcomes”. Journal of Neurooncology2 (2019): 347-354.
- Diamantopoulos LN., et al. “Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature”. Clinical Genitourinary Cancer 3 (2020): e266-e276.
- Schiff D and O'Neill BP. “Intramedullary spinal cord metastases: clinical features and treatment outcome”. Neurology4 (1996): 906-912.
- Hrabalek L. “Intramedullary spinal cord metastases: review of the literature”. Biomedical Papers is a Journal of Palacký University Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czech Republic 2 (2010): 117-122.
- Lv J., et al. “Intramedullary spinal cord metastasis in malignancies: an institutional analysis and review”. OncoTargets and Therapy 12 (2019): 4741-4753.
- Kalayci M., et al. “Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review”. Acta Neurochirurgica (Wien) 2004 146.12 (2004): 1347-1354 discussion 54.
- Rykken JB., et al. “Intramedullary spinal cord metastases: MRI and relevant clinical features from a 13-year institutional case series”. AJNR American Journal of Neuroradiology10 (2013): 2043-2049.
- Strickland BA., et al. “The surgical treatment of metastatic spine tumors within the intramedullary compartment”. Journal of Neurosurgey Spine1 (2018): 79-87.
- Gasser T., et al. “Surgical treatment of intramedullary spinal cord metastases of systemic cancer: functional outcome and prognosis”. Journal of Neurooncology2 (2005): 163-168.